Aurora Cannabis is a Canadian medical cannabis company that is committed to providing cannabis at affordable prices, flat-rate compassionate pricing, and with free-shipping throughout Canada. The brand takes care of its product from seed to sale, and works to provide users with the quality that they are looking for.
A recent article by Yahoo Finance! Discussed the current discussions surrounding the marijuana product brand. According to the article, some believe that Aurora is “the best marijuana stock on the market.” Aurora’s success has also led the company to consider remaining independent, rather than adding an equity partner.
However, the Yahoo Finance! Article notes that the company’s decision “wouldn’t be a problem if Aurora were generating a solid profit. It’s not. Although the company expects to generate positive EBIDA this quarter, the reality is that Aurora will still probably have to raise more money – especially if it keeps up its buying spree of smaller companies.”
If Aurora were to choose a partnership though, there are those that are considering which would be the right company for Aurora to partner with. The Motley Fool has lined up three possible contenders, such as Aphira, Organigram, and HEXO.
According to the article, these companies are potential options for their own individual reasons. For instance, Aphira is ranked third behind Aurora and Canopy concerning production capacity, and it has a solid international presence. Next, Organigram also has impressive production capacity, and it has supply agreements with nine provinces. Lastly, HEXO has impressive supply agreements and it has been viewed positively by Wall Street analysts.
Whatever Aurora Cannabis decides to do, it will certainly be interesting to see the outcomes.